| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $23K | — | -7.3% |
| Cost of Revenue | $7K | — | +153.9% |
| Gross Profit | $16K | — | -28.5% |
| R&D Expense | $1.9M | — | +12.4% |
| SG&A Expense | $1.5M | — | -52.6% |
| Operating Income | -$3.4M | — | +29.6% |
| Net Income | -$2.2M | — | +59.7% |
| EPS (Basic) | -$0.12 | — | +81.3% |
| EPS (Diluted) | -$0.12 | — | +81.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $3.1M | +106.0% | +153.3% |
| Short-term Investments | $479K | -66.8% | -93.9% |
| Accounts Receivable | $13K | -14.2% | -46.8% |
| Current Assets | $3.8M | +21.1% | -59.4% |
| Total Assets | $4.6M | +13.7% | -55.1% |
| Current Liabilities | $1.6M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.8M | — | -37.0% |
| Capital Expenditures | $36K | — | +0.0% |
| Investing Cash Flow | $968K | — | -59.1% |
| Financing Cash Flow | $4.4M | — | +306.4% |
| Free Cash Flow | -$3.8M | — | -36.6% |
| -61.4% |
| Stockholders' Equity | $3.0M | +748.1% | -50.8% |